This study aimed to investigate the effect of manipulating PGC-1α pathway (activating PGC-1α by rosiglitazone or silencing PGC-1α) on the skeletal muscle of SOD1(G93A) ALS mouse model. Here, SOD1 is linked to amyotrophic lateral sclerosis.